Boston Children's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT03722706
The objective of this research is to evaluate the effectiveness of an educational handbook for parents of children with atopic dermatitis (AD) in improving clinical outcomes for pediatric patients with AD and their parents. The handbook was developed by an interdisciplinary team of healthcare providers to facilitate therapeutic patient education as a routine component of care for pediatric patients with atopic dermatitis (AD). Patient education is an important element of practice management guidelines for AD, particularly given complex treatment plans and high rates of non-adherence in this population. Parents of children with AD will be randomized into either the handbook arm (handbook provided as an adjunct to standard AD management with a healthcare provider at Boston Children's Hospital) or the control arm (standard management alone). Participants will complete study measures at two time points: baseline (prior to a clinic visit appointment for AD care at Boston Children's Hospital), and 3-month follow-up. Data will be analyzed for change on study outcome measures (AD symptoms, AD severity, quality of life) and satisfaction with the handbook.
Looking for future studies?
Notify Me30 day–16 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention being evaluated in this study is an educational handbook for parents of children with atopic dermatitis (AD). The handbook was developed and written by the interdisciplinary study team (psychologist, allergist, nurse practitioner, dermatologists, primary care physician, dietitian). Content was based on practice guidelines for AD management, consensus recommendations for therapeutic patient education for AD, and clinical experience of our study team. Content includes topics central to effective AD management, such as pathophysiology/course, elements of treatment plans, and strategies to improve quality of life, such as breaking the itch-scratch cycle, improving sleep, and coping with social-emotional issues.
Time frame: baseline to 3-month follow-up
parent-report of child's atopic dermatitis symptoms
Time frame: baseline to 3-month follow-up
healthcare provider-rating of atopic dermatitis severity
Time frame: baseline to 3-month follow-up
Quality of life associated with atopic dermatitis (for patients under 4 years)
Time frame: baseline to 3-month follow-up
Quality of life associated with atopic dermatitis (for patients 4-16 years)
Time frame: baseline to 3-month follow-up
Parent quality of life associated with atopic dermatitis
Boston Children's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06324812
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT04365387
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Phoenix, Arizona, United States
View Trial DetailsNCT06173284
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT03422822
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Birmingham, Alabama, United States
View Trial Details